Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-19

Clinical Trial Update: Effects of Photobiomodulation in Children With Down Syndrome and Possible Sleep Bruxism [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trials evaluating photobiomodulation in children with down syndrome who may have sleep bruxism have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Photobiomodulation Therapy

Snippet

Sponsor: University of Nove de Julho | Conditions: Sleep Bruxism | Phase 1, Phase 2 | Status: COMPLETED